“Neurofilament light (NfL) in serum as a prognostic biomarker for brain damage and later neurodevelopment in infants with birth asphyxia” is a study in which we investigate neurofilament light (NfL) as a marker for brain damage and how it can be used in assessing prognosis for future neurodevelopment after asphyxia. A previous smaller pilot study […]
Read More
Fortification of breast milk with a very expensive product based on concentrated human milk does not improve the health of extremely preterm infants, compared to a standard fortifier. This is shown in a Swedish study of international interest, with the participation of Umeå, Linköping, Göteborg, Stockholm and Uppsala. Magnus Domellöf is in the steering committee […]
Read More
We are very happy to announce that the NorthPop research infrastructure has received a grant of 4 million SEK from the the Kempe Foundations (Kempestiftelserna) for 2024-2026. The grant will go towards completion of the first phase of building the research infrastructure, which includes recruiting the remaining participants (expected May 2025) and that all children in […]
Read More
We wish a Merry Christmas to all our team members, collaborators, funders and not least all the children and families participating in our research! We look back on a year with several exciting new projects, lots of publications, new research grants and one where we welcomed several new team members! We look forward to the […]
Read More
‘The impact of mild maternal nutrient deficiency in the fetal brain – the SWIDDICH study’ has received a grant of just over 12 million SEK in the category ‘clinical study in therapy research’ from the Swedish Research Council for the period 2024-2027. The purpose of the study is to prevent micronutrient deficits in pregnant women […]
Read More
We are pleased to announce that the project led by Prof Magnus Domellöf entitled Effects of early nutrition on brain development and cognitive/behavioral problems in children has received a grant of 4,8 million SEK from the Swedish Research Council for the period 2024-2027. The project includes a series of randomized, controlled clinical trials aiming to […]
Read More
There has been some recent media coverage of NorthPop and the start of the 7-year follow-up in Umeå. Principal investigator Magnus Domellöf was interviewed by Västerbottens Kuriren (in Swedish):https://www.vk.se/2023-11-07/9-fragor-jag-kanner-stort-ansvar-men-ocksa-stor-stolthet-8892b Local TV news SVT Västerbotten attended the pediatric research unit at Umeå University Hospital when Charlie and his mum Kristin Simonsson were there for Charlie’s follow-up […]
Read More
We are pleased to announce that the Intervention for Neurodevelopmental Support in Preterm Infants using Responsive parenting and E-health or ‘INSPIRE’ study has received a grant of 3,7 million SEK from the Swedish Research Council for Health, Working Life and Welfare (FORTE) for 2024-2026. INSPIRE is a new, e-health initiative aimed at parents of very […]
Read More
The NorthPop study has reached another milestone with the 7-year follow-up now underway in Umeå. Participating families are contacted around the child’s 7th birthday and asked to make an appointment at the pediatric research unit at Umeå University Hospital. During the visit to the unit the research nurses take a blood sample and a skin […]
Read More
The ‘Growth, ALlergy and NeuroDevelopment in Infants On hydrolySed formulA’, or GRANDIOSA study started up in late 2022. It is conducted at two study sites: Umeå and Malmö and the purpose of the study is to determine the effects of two novel protein hydrolysates on infants’ growth, neurological development, allergies, gastrointestinal symptoms and other health […]
Read More